Viromed Medical AG (HAM:VMED) EV-to-EBITDA : -1,323.81 (As of May. 20, 2025)

Viromed Medical AG EV-to-EBITDA Chart

Competitive Comparison of Viromed Medical AG's EV-to-EBITDA

For the Medical Devices subindustry, Viromed Medical AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viromed Medical AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Viromed Medical AG's EV-to-EBITDA falls into.

Viromed Medical AG EV-to-EBITDA Calculation

Viromed Medical AG's EV-to-EBITDA for today is calculated as:

Viromed Medical AG's current Enterprise Value is €103.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Viromed Medical AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG  (HAM:VMED) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Viromed Medical AG's PE Ratio (TTM) for today is calculated as:

Viromed Medical AG's share price for today is €5.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Viromed Medical AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Viromed Medical AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Viromed Medical AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Viromed Medical AG Business Description